5
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen

, , , , , , , , & show all
Pages 35-53 | Published online: 04 Dec 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer & Erika Vacchelli. (2020) Trial watch: TLR3 agonists in cancer therapy. OncoImmunology 9:1.
Read now
William M Mitchell. (2016) Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). Expert Review of Clinical Pharmacology 9:6, pages 755-770.
Read now
Paul H. Levine, Nancy Klimas, Roseanne Armitage, Robert Fredericks, Julian Stewart, William Torch, Stanley Schwartz, Robert Suhadolnik, Nancy L. Reichenbach & Lea Rhodes. (2001) Nevada Chronic Fatigue Syndrome Consensus Conference. Journal Of Chronic Fatigue Syndrome 9:1-2, pages 53-62.
Read now
Christopher R. Snell, Staci R. Stevens & J. Mark Vanness. (2001) Chronic Fatigue Syndrome, Ampligen, and Quality of Life. Journal Of Chronic Fatigue Syndrome 8:3-4, pages 117-121.
Read now
Alan M. Cocchetto, Mary E. McNamara & Edward F. Jordan. (2000) Human Herpes Virus 6 (HHV-6) Infection in Patients with Chronic Fatigue Syndrome and Its Relationship to Activation-Induced Cell Death. Journal Of Chronic Fatigue Syndrome 6:3-4, pages 41-50.
Read now
Charles W. Lapp. (1997) Management of Chronic Fatigue Syndrome in Children. Journal Of Chronic Fatigue Syndrome 3:2, pages 59-76.
Read now

Articles from other publishers (8)

Hassana el Haddaoui, Rianne Brood, Diba Latifi, Astrid A. Oostvogels, Yarne Klaver, Miranda Moskie, Dana A. Mustafa, Reno Debets & Casper H. J. van Eijck. (2022) Rintatolimod (Ampligen®) Enhances Numbers of Peripheral B Cells and Is Associated with Longer Survival in Patients with Locally Advanced and Metastasized Pancreatic Cancer Pre-Treated with FOLFIRINOX: A Single-Center Named Patient Program. Cancers 14:6, pages 1377.
Crossref
Spencer Richman, Matthew C. Morris, Gordon Broderick, Travis J.A. Craddock, Nancy G. Klimas & Mary Ann Fletcher. (2019) Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary. Clinical Therapeutics 41:5, pages 798-805.
Crossref
N. Cary Engleberg. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 1674 1680.e3 .
Joseph H. Brewer. 2006. Human Herpesvirus-6, Second Edition - General Virology, Epidemiology and Clinical Pathology. Human Herpesvirus-6, Second Edition - General Virology, Epidemiology and Clinical Pathology 337 342 .
Daniel Peterson & Lisa Atwell. 2006. Human Herpesvirus-6, Second Edition - General Virology, Epidemiology and Clinical Pathology. Human Herpesvirus-6, Second Edition - General Virology, Epidemiology and Clinical Pathology 251 262 .
Leonard A. Jason & Renee R. Taylor. 2003. Handbook of Psychology. Handbook of Psychology.
Kenny De Meirleir, Karen De Smet, Pascale De Becker & Neil McGregor. 2002. Chronic Fatigue Syndrome. Chronic Fatigue Syndrome 229 263 .
Dharam V. Ablashi, Paul H. Levine, Caterina De Vinci, James E. WhitmanJr.Jr., Giancarlo Pizza & Dimitri Viza. (1996) Use of anti HHV-6 transfer factor for the treatment of two patients with chronic fatigue syndrome (CFS). Two case reports. Biotherapy 9:1-3, pages 81-86.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.